March 3, 2020
Antares Pharma reported operating and financial results for the fourth quarter and full year ended December 31, 2019.
January 27, 2020
Antares announced its 2020 net revenue guidance of US$135 to US$155 million, which includes potential revenue scenarios for AMAG’s Makena.
November 28, 2018
The EpiPen and this generic equivalent are indicated for the emergency treatment of severe allergic reactions.
November 27, 2018
Antares Pharma (NASDAQ:ATRS) announced that Teva Pharmaceutical Industries generic EpiPen is now commercially available in limited quantities. As quoted in the...
October 1, 2018
Antares Pharma (NASDAQ:ATRS) today announced the approval of XYOSTED (testosterone enanthate) injection by the U.S. Food and Drug Administration (FDA)....
August 17, 2018
Antares Pharma (NASDAQ:ATRS) announced that the U.S. Food and Drug Administration (FDA) has approved Teva Pharmaceutical, epinephrine auto injector drug-device...